Explore
← New search
Filters:
Front Oncol
✕
drug sensitivity assay (organoid size change)
✕
primary crc tumor tissue (human surgical specimens)
✕
clear all
1 matching publication(s)
Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients.
PMID 35425715 · Front Oncol · 2022
L1
53/100